Michael Voelker

1.8k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Michael Voelker is a scholar working on Pharmacology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Voelker has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Ophthalmology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Voelker's work include Retinal Diseases and Treatments (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Respiratory and Cough-Related Research (5 papers). Michael Voelker is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Respiratory and Cough-Related Research (5 papers). Michael Voelker collaborates with scholars based in Germany, United States and United Kingdom. Michael Voelker's co-authors include Michael Becka, Detlef Schuppan, Massimo Pinzani, Robert Thiel, Stefan G. Hübscher, William Rosenberg, Tania Roskams, Michael J.P. Arthur, Alastair D. Burt and Karl Ulrich Bartz‐Schmidt and has published in prestigious journals such as Gastroenterology, Acta Neuropathologica and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Michael Voelker

27 papers receiving 1.3k citations

Hit Papers

Serum markers detect the presence of liver fibrosis: A co... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Voelker Germany 14 834 661 156 139 122 27 1.3k
Takeshi Nishimura Japan 19 575 0.7× 207 0.3× 17 0.1× 351 2.5× 258 2.1× 110 1.3k
Kamal G. Ishak United States 8 389 0.5× 355 0.5× 21 0.1× 113 0.8× 208 1.7× 8 1.2k
D H Van Thiel United States 18 274 0.3× 333 0.5× 22 0.1× 107 0.8× 209 1.7× 44 950
Ming-Chih Hou Taiwan 22 956 1.1× 995 1.5× 9 0.1× 175 1.3× 493 4.0× 101 1.7k
Gilbert R. Cherrick United States 10 241 0.3× 171 0.3× 77 0.5× 140 1.0× 246 2.0× 16 1.1k
Ying Dai China 18 274 0.3× 321 0.5× 8 0.1× 96 0.7× 136 1.1× 58 865
Marcella Savoia Italy 10 371 0.4× 102 0.2× 18 0.1× 126 0.9× 70 0.6× 27 625
Antonio De Vincentis Italy 18 411 0.5× 164 0.2× 9 0.1× 96 0.7× 178 1.5× 65 891
Erol Avşar Türkiye 20 746 0.9× 329 0.5× 5 0.0× 258 1.9× 227 1.9× 40 1.3k
Laurence Chauvelot‐Moachon France 19 261 0.3× 183 0.3× 6 0.0× 213 1.5× 176 1.4× 33 1.2k

Countries citing papers authored by Michael Voelker

Since Specialization
Citations

This map shows the geographic impact of Michael Voelker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Voelker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Voelker more than expected).

Fields of papers citing papers by Michael Voelker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Voelker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Voelker. The network helps show where Michael Voelker may publish in the future.

Co-authorship network of co-authors of Michael Voelker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Voelker. A scholar is included among the top collaborators of Michael Voelker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Voelker. Michael Voelker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voelker, Michael, et al.. (2020). Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations. European Journal of Pharmaceutics and Biopharmaceutics. 151. 9–17. 25 indexed citations
2.
Voelker, Michael, et al.. (2016). Dissolution rates of over-the-counter painkillers: a comparison among formulations.. PubMed. 107(3). 125–30. 3 indexed citations
4.
Eccles, Ronald & Michael Voelker. (2013). Analgesic and decongestant efficacy of the combination of aspirin with pseudoephedrine in patients with symptoms of upper respiratory tract infection. Clinical Pharmacology in Drug Development. 3(2). 118–125. 10 indexed citations
5.
Baron, John A., Stephen Senn, Michael Voelker, et al.. (2013). Gastrointestinal Adverse Effects of Short-Term Aspirin Use: A Meta-Analysis of Published Randomized Controlled Trials. Drugs in R&D. 13(1). 9–16. 20 indexed citations
6.
Seven, Gülseren, Senem Ceren Karataylı, Serdal Kenan Köse, et al.. (2011). Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D. The Turkish Journal of Gastroenterology. 22(3). 305–314. 17 indexed citations
8.
Lampl, Christian, Michael Voelker, & Timothy J. Steiner. (2011). Aspirin is First‐Line Treatment for Migraine and Episodic Tension‐Type Headache Regardless of Headache Intensity. Headache The Journal of Head and Face Pain. 52(1). 48–56. 10 indexed citations
9.
Lanas, Ángel, Denis M. McCarthy, Michael Voelker, et al.. (2011). Short-Term Acetylsalicylic Acid (Aspirin) Use for Pain, Fever, or Colds —Gastrointestinal Adverse Effects. Drugs in R&D. 11(3). 277–288. 37 indexed citations
10.
Voelker, Michael, et al.. (2011). Gastrointestinal Effects of the Addition of Ascorbic Acid to Aspirin. Pain Practice. 12(6). 476–484. 4 indexed citations
11.
Voykov, Bogomil, Faik Gelişken, W. Inhoffen, et al.. (2010). Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(4). 543–550. 34 indexed citations
12.
Schachtel, Bernard, et al.. (2010). Demonstration of the Analgesic Efficacy and Dose‐Response of Acetylsalicylic Acid With Pseudoephedrine. The Journal of Clinical Pharmacology. 50(12). 1429–1437. 13 indexed citations
13.
Gelişken, Faik, Michael Voelker, Rainer Schwabe, et al.. (2007). Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefe s Archive for Clinical and Experimental Ophthalmology. 245(8). 1085–1095. 29 indexed citations
14.
Ziemssen, Focke, Michael Voelker, Elke Altpeter, Karl Ulrich Bartz‐Schmidt, & Faik Gelişken. (2007). Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma. Acta Ophthalmologica Scandinavica. 85(5). 579–580. 19 indexed citations
15.
Diener, Hans‐Christoph, Christian Lampl, Peter Reimnitz, & Michael Voelker. (2006). Aspirin in the treatment of acute migraine attacks. Expert Review of Neurotherapeutics. 6(4). 563–573. 28 indexed citations
17.
Lebensztejn, Dariusz, M Sobaniec‐Lotowska, Michael Bauer, et al.. (2005). Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B. European Journal of Gastroenterology & Hepatology. 17(8). 843–848. 21 indexed citations
18.
Gelişken, Faik, et al.. (2004). Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization. Graefe s Archive for Clinical and Experimental Ophthalmology. 243(3). 198–203. 6 indexed citations
19.
Schuettauf, Frank, Robert Ręjdak, M Walski, et al.. (2004). Retinal neurodegeneration in the DBA/2J mouse?a model for ocular hypertension. Acta Neuropathologica. 107(4). 352–358. 91 indexed citations
20.
Burchardt, Elmar R., Michael Heke, Stefan G. Kauschke, et al.. (1998). Epitope-specific monoclonal antibodies against human c-terminal procollagen α1(III)-propeptide. Matrix Biology. 17(8-9). 673–677. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026